About Medafor
Medafor is a company based in Minneapolis (United States) founded in 1999 by James Drake was acquired by CR Bard in August 2013. Medafor has raised $15 thousand across 2 funding rounds from investors including CR Bard. Medafor operates in a competitive market with competitors including Abyrx, Biom'Up, Prytime Medical Devices, Endomedix and United Health Products, among others.
- Headquarter Minneapolis, United States
- Founders James Drake
- SectorsHealthcare
- Email••••••••
- Website medafor.com
- Social LinkedIn X
- Acquired by CR Bard (Aug 2013)
Funding Insights of Medafor
Medafor has successfully raised a total of $15K across 2 strategic funding rounds. The most recent funding activity was a Unspecified round of $15 thousand completed in September 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $15,000
- Total Rounds 2
- Last Round Unspecified — $15,000
- First Round $100,000
(Sep 2009)
All 2 funding rounds of Medafor with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2012 | $15,000 | Unspecified | – | – | – |
| Sep 2009 | $100,000 | Debt – Convertible | – | – | – |
1 investors in total: 1 institutional.
Investors in Medafor
Medafor has secured backing from 1 investor. Prominent investors backing the company include CR Bard.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Products for vascular, urology, oncology, and surgical specialties | 1907 | crbard.com | Murray, United States |
Investor details for Medafor
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Medafor
1 people are tracked at Medafor (1 in leadership).
| Name | Role | Group |
|---|---|---|
James Drake | Co-Founder | Leadership |
Complete people profiles for Medafor
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Medafor
4 dated milestones of Medafor across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Medafor is founded.
- Funding First funding round of $100K.
- Funding Latest funding round, Unspecified, of $15K.
- Exit Acquired by CR Bard.
Competitors of Medafor
Medafor operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abyrx, Biom'Up, Prytime Medical Devices, Endomedix and United Health Products, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abyrx.com | 2013 | Irvington, United States | $10M | – | Hemostatic bone putty is developed for surgical bone bleeding control. | |
| biomup.com | 2005 | Saint Priest Bramefant, France | $43.82M | – | Hemostatic products for surgical applications are developed using collagen-based materials. | |
| prytimemedical.com | 2011 | Boerne, United States | $10M | 41 | Developer of minimally invasive large vessel occludes for hemorrhage control in trauma patients | |
| endomedix.com | 2005 | Newark, United States | $1.99M | – | Hydrogel solutions for surgery and wound care are developed. | |
| uhpcorp.com | 1997 | Mesquite, United States | – | – | Medical device for hemostasis during surgical procedures is provided. | |
| life-bond.com | 2007 | Caesarea, Israel | $56.5M | – | Absorbable surgical sealants and hemostats are developed for leakage prevention. | |
| obsidiomed.com | 2018 | Solana Beach, United States | $3M | – | Shear-thinning biomaterial is developed to control blood flow minimally invasively. | |
| fusionmed.com | 1992 | Fremont, United States | – | – | Collagen-derived particles and thrombin are utilized for surgical hemostasis. | |
| archtherapeutics.com | 2006 | Natick, United States | $320,000 | 8 | Hemostasis and sealant technology | |
| surgrx.com | 2001 | Redwood, United States | $62.5M | – | Tissue sealing and hemostasis systems are developed for laparoscopic surgery. |
Detailed competitors of Medafor
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Medafor
10 companies that operate in the same segment as Medafor (Medical Equipment & Supplies), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Software and integrated solutions for surgical and radiotherapy applications | 1989 | Munchen, Bayern, Germany | USD 12.68 M | USD 1.18 M | 18 | |
Robotic waterjet system for prostate tissue removal is developed. | 2009 | Redwood City, California, United States | USD 348.84 M | USD 308.05 M | 756 | |
Collaborative surgical robotic systems are provided for hospital procedures. | 2014 | Cambridge, Cambridgeshire, United Kingdom | USD 1.32 B | – | – | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.17 M | – | 242 | |
Augmented reality systems for guiding surgical procedures are developed. | 2014 | Yokneam Illit, North District, Israel | USD 142.6 M | – | – | |
Manufacturer of imaging and surgical products | 1919 | Tokyo, Tokyo, Japan | – | USD 6.49 B | 35,933 | |
Injectable packaging, containment, and delivery solutions are manufactured. | 1923 | Exton, Pennsylvania, United States | – | USD 3.07 B | 10,600 | |
Rapid infusion systems are provided for critically ill patients. | 2012 | Durham, North Carolina, United States | USD 77.98 M | – | – | |
Mobile robots are manufactured for industries including healthcare and agriculture. | 2013 | Odense, Denmark | USD 81.44 M | – | 303 | |
Visualization systems for surgical procedures are developed using machine learning. | 2016 | Seattle, Washington, United States | USD 74.25 M | – | 52 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Medafor
Medafor was founded in 1999 and raised its 1st funding round 10 years after it was founded.
Medafor is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.
Medafor is a funded company, having raised a total of $15K across 2 funding rounds to date. The company's 1st funding round was a Debt – Convertible of $100K, raised on Sep 2009.
Medafor was established in 1999 in Minneapolis, United States, as a medical device company. A patented hemostatic agent derived from purified plant starch was developed and commercialized to support blood clotting in surgical settings. The product Arista, an absorbable powder, was used as an adjunct in procedures involving capillary, venous, and arteriolar bleeding, excluding neurologic and ophthalmic applications. Acquisition by Bard occurred in 2013.
Medafor's top competitors include Prytime Medical Devices, Arch Therapeutics and Biom'Up.
Medafor has 1 investor. Key investors include CR Bard.
Yes. Medafor was acquired by CR Bard in August 2013.